BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors.

Paculova H, Kramara J, Simeckova S, Fedr R, Soucek K, Hylse O, Paruch K, Svoboda M, Mistrik M, Kohoutek J
Tumour Biol. 2017 Oct;39(10):1010428317727479. doi: 10.1177/1010428317727479. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.